Description

This research formulation combines BPC-157 and TB-500, two peptides widely studied for their regenerative and anti-inflammatory properties. Together, they may provide synergistic support for cellular repair, tissue regeneration, and recovery in preclinical models involving musculoskeletal injury, inflammation, and vascular integrity.

BPC-157, a stable gastric pentadecapeptide, has been studied for promoting angiogenesis, collagen formation, and healing in soft tissue and gastrointestinal injury models. TB-500, a synthetic version of the naturally occurring thymosin beta-4, is known to modulate actin dynamics and support wound healing, cell migration, and inflammation control.

Mechanism of Action (Based on Preclinical Research):

• BPC-157: Stimulates angiogenesis, collagen synthesis, and tendon/ligament regeneration

• TB-500: Enhances cellular migration, reduces inflammation, and accelerates tissue recovery

• May act synergistically to improve repair in muscle, tendon, nerve, and vascular tissue

Potential Benefits (Based on Preclinical Research):

• Accelerated healing of muscles, tendons, and ligaments

• Reduced inflammation and oxidative stress

• Enhanced blood flow and capillary regeneration

• Supports recovery in models of injury and trauma

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research purposes.